TCL Archive With NIH “Accountability” As Background, Advocates Support Budget Increases. March 30, 2001
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005
TCL Archive Research Funding: Clinton Proposes 2.6% Increase For NIH, Amount Called “Paltry” February 14, 1997
